This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline LLC. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: John J Trill: Innovator in Protein Expression Technology.
Introduction
John J Trill is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of protein expression technology. His work focuses on the use of innovative methods to enhance protein production in mammalian cells.
Latest Patents
John J Trill holds a patent for the invention titled "Expression of protein GB1 domain fusion proteins in mammalian cells." This invention relates to the use of the B1 domain of Protein G as an epitope tag for the over-expression of proteins in mammalian cells. His patent represents a valuable advancement in biotechnological applications.
Career Highlights
John J Trill is associated with GlaxoSmithKline LLC, where he applies his expertise in protein expression. His work has contributed to the development of new therapeutic proteins and has implications for various medical applications.
Collaborations
John collaborates with Kyung Oh Johanson, enhancing the research and development efforts within their field. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
John J Trill's contributions to protein expression technology highlight his role as an innovator in the biotechnology sector. His patent and work at GlaxoSmithKline LLC demonstrate the impact of his research on advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile